Biological Assay: In Vitro Safety test Mycoplasma and Adventitious Agents

Size: px
Start display at page:

Download "Biological Assay: In Vitro Safety test Mycoplasma and Adventitious Agents"

Transcription

1 Biological Assay: In Vitro Safety test Mycoplasma and Adventitious Agents Supaporn Phumiamorn (Ph.D, Virology) Institute of Biological Products (IBP) 11 March 2016 Supaporn Phumiamorn 11 March

2 1956, first report on mycoplasma detection in cell culture by Robinson et. Al , some extensive studies in the US samples Mycoplasma (15% infected cell cultures) -CCL, DCL and PCC Supaporn Phumiamorn 11 March

3 Mycoplasma the simplest self-replicating prokaryotes. infect a wide variety of eukaryotic hosts including humans, animals (birds, reptiles, fish, mammals), insects, plants, and bovine. resistant to penicillin and can squeeze through 0.2-µm and 0.45-µm membranes routinely used for sterile filtration. Supaporn Phumiamorn 11 March

4 frequent contaminants of cell cultures. biologic products prepared using cell culture substrates expected to be free of mycoplasma to assure safety, purity, potency, and consistency. Supaporn Phumiamorn 11 March

5 Mycoplasma contamination Altered growth rate Morphology changes Chromosome aberrations Alterations in amino acid and nucleic acid metabolism Dead Supaporn Phumiamorn 11 March

6 Uphoff C.C and Drexler H.G Prevalence 15-35% CCLs 5% early passage cell cultures 1% PCCs Most common species 20-40% M. orale (human, egg) 10-40% M.hyorhinis (swine) 20-30% M. arginini (bovine) 10-20% M. hominis (human) 10-20% M. fermentans (human, egg) 5-20% A. laidlawi (bovine) Supaporn Phumiamorn 11 March

7 Source of mycoplasma contamination Cross-contamination from infected cultures Original tissue isolate (less than 1%) Supaporn Phumiamorn 11 March

8 Mycoplasma detection Bacterial culture DNA staining (epifluorescence in cell culture) PCR PCR and microarray (DNA microarray testing) ELISA etc. Supaporn Phumiamorn 11 March

9 Supaporn Phumiamorn 11 March

10 Supaporn Phumiamorn 11 March

11 Mycoplasma detection Supaporn Phumiamorn 11 March

12 Adventitious agent Manufacture of Biological Products Manufacture of a large class of biological products, including vaccines and cell and gene therapy products, often requires use of cell substrates and raw materials of animal origin. Potential risk that cell substrates and raw materials can be contaminated with adventitious agents (endogenous and exogenous) Supaporn Phumiamorn 11 March

13 Adventitious agent contaminating microorganisms of the cell culture or source materials (bacteria, fungi, mycoplasma/spiroplasmas, mycobacterium, rickettsia, protozoa, parasites, transmissible spongiform encephalopathies (TSE) agents and viruses) Supaporn Phumiamorn 11 March

14 Potential concern that adventitious agents can be unintentionally introduced into the manufacturing process Supaporn Phumiamorn 11 March

15 Current Methods of Detection of Adventitious Agents Methods evolved over time; in many ways recapitulate the history of virus discovery Infectivity assays in animals and cell culture Non-specific methods known/unknown agents - in vivo (animals) - in vitro (cell culture) - molecular/biochemical Specific methods known agents - molecular, e.g., PCR (Arifa S. Khan, CBER, USA 2005) Supaporn Phumiamorn 11 March

16 Non-Specific Methods: In Vivo Systems Various animal models used, e.g., adult mice, suckling mice, embryonated hens eggs, guinea pigs, rabbits These tests originally used because they detected viruses not readily detected in other systems (Arifa S. Khan, CBER, USA 2005) Supaporn Phumiamorn 11 March

17 Non-Specific Methods: In Vivo Systems Examples of viruses detected in mice include: cocksackie A & B viruses; picornaviruses (polioviruses, echoviruses); alphaviruses; bunyaviruses (phleboviruses, nairoviruses); arenaviruses; flaviviruses; rabies virus; herpesviruses; lymphocytic choriomeningitis virus; also various murine viruses Examples of viruses detected in eggs include: orthomyxoviruses; paramyxoviruses; alphaviruses; vesiculoviruses; herpesviruses; poxviruses; rhabdoviruses (Arifa S. Khan, CBER, USA 2005) Supaporn Phumiamorn 11 March

18 Adventigious agent Extraneous agent using animals - Mice - Sucking mice -Guinea pigs -embryonated hens egg Supaporn Phumiamorn 11 March

19 Limitations of In Vivo Tests Sensitivity is unknown for wild-type strains, as methods were usually established with laboratory-adapted strains Many viruses pathogenic for humans do not infect or replicate in rodents or eggs. (Arifa S. Khan, CBER, USA 2005) Supaporn Phumiamorn 11 March

20 Antibody-Production Tests Test article is inoculated into animals, and an adventitious agent is detected by the presence of antibodies to that agent Mainly performed on cell substrates when there is a possibility of exposure to rodent agents (Arifa S. Khan, CBER, USA 2005) Supaporn Phumiamorn 11 March

21 Antibody-Production Tests Viruses detected include: ectromelia virus, mouse rotavirus, Hantaan virus, Lymphocytic choriomeningitis virus, lactate dehydrogenase virus, minute virus of mice; mouse adenovirus, murine cytomegalovirus, mouse encephalomyelitis virus, mouse hepatitis virus, pneumonia virus of mice, polyoma virus, reovirus type 3, Sendai virus, thymic virus, K virus, simian virus 5, mouse encephalomyelitis virus, Hantaan virus, Kilham rat virus, mouse adenovirus, rat coronavirus, Toolan virus, sialdacryoadenitis virus (Arifa S. Khan, CBER, USA 2005) Supaporn Phumiamorn 11 March

22 Non-Specific Tests: In Vitro Systems Methods are based on the ability of cell cultures to grow a wide array of pathogens; also based on their extensive use in diagnostic laboratories to detect human pathogens Large amount of inocula can be applied, thus increasing their sensitivity Cell-culture tests can detect a variety of adventitious viruses, including cytopathic viruses, hemadsorbing viruses, and hemagglutinating viruses Selection of the cell line depends upon the potential exposure to agents (species and tissue type of cell substrate; human diploid cells; monkey kidney cells) (Arifa S. Khan, CBER, USA 2005) Supaporn Phumiamorn 11 March

23 Adventigious agent Extraneous agent using cell lines - sensitive cell lines (Vero and MRC-5) - induce Cytopathic Effect (CPE) or haemadsorbing activity (Arifa S. Khan, CBER, USA 2005) Supaporn Phumiamorn 11 March

24 Adventigious agent Extraneous agent: Any viral contaminants Positive viruses -Adenovirus-5 -Reovirus-3 -parainfluenza type 3 -HSV-1 Supaporn Phumiamorn 11 March

25 Adventitious agent Supaporn Phumiamorn 11 March

26 Adventitious agent Extraneous agent: Any viral contaminants Supaporn Phumiamorn 11 March

27 Heamagglutination Supaporn Phumiamorn 11 March

28 Cell-Culture Method: Readout Evidence of virus contamination indicated by: Cytopathic effects in culture For non-cytopathic viruses, test at the end of the observation period for: hemadsorption (binding of red blood cells from human, rhesus macaque, guinea pig, chicken) hemagglutination (agglutinate red blood cells) Other readouts can be used, such as antibody staining, PCR, etc. (Arifa S. Khan, CBER, USA 2005) Supaporn Phumiamorn 11 March

29 Limitations of In Vitro Tests Only can detect agents that can infect and propagate in indicator cells Sensitivity is unknown for wild-type strains, as methods were usually established with laboratory-adapted strains Many viruses pathogenic for humans do not infect or replicate readily in culture (e.g., HPV, HCV) (Arifa S. Khan, CBER, USA 2005) Supaporn Phumiamorn 11 March

30 Other Non-Specific Tests Transmission Electron Microscopy Can detect virus particles in a cell substrate, including those from endogenous viruses Morphology provides indication of the type of viral contaminant Insensitive assay generally considered to require 10 6 particles per ml to be detected Qualitative assay; a positive result would require additional tests (e.g., PCR, infectivity) Supaporn Phumiamorn 11 March

31 Reverse Transcriptase (RT) Assay for Retrovirus Detection All retroviruses have RT in their virions; therefore, these assays can detect all retroviruses Quantitative PERT assays are now recommended Some cell substrates express non-infectious endogenous retroviral particles, e.g., eggs, chick embryo fibroblasts, CHO cells Because of high assay sensitivity, false positive signals can be obtained from cell lysates Positive result may require infectivity assays Supaporn Phumiamorn 11 March

32 Specific Tests for Viruses PCR Tests When viruses are of concern in a specific product, additional testing is recommended Such tests are based on the virus sequence Conventional PCR and qpcr Partially degenerate primer PCR that detects members of a virus family Examples: - Human pathogens in certain human cells: HIV, HCV, etc. When warranted, PCR tests for various animal viruses are recommended Supaporn Phumiamorn 11 March

33 Novel Molecular Methods for Adventitious Agent Detection Supaporn Phumiamorn 11 March

34 Strategy for Adventitious Agent Detection Sample selection Cellular genome (DNA) Transcriptome (RNA) Virus particle Amplification schemes Family-specific primers Degenerate primers, etc. Detection methodologies Mass spectrometry Microarray High-throughput sequencing (Arifa S. Khan, CBER, USA 2005) Supaporn Phumiamorn 11 March

35 Considerations with New Generation Molecular Methods Sensitivities usually not determined Do not indicate whether virus is infectious Each different method may require different types of standardization and standards to be used in a regulatory context Breadth of detection not studied Reproducibility or robustness generally not known Many techniques are not commercially available Many results will require follow up Supaporn Phumiamorn 11 March

36 Adventitious Agents: A Continuing Challenge Novel viruses are being discovered and will continue to be discovered Many of these could be present as adventitious agents of cell substrates or biological products New cell substrates from insects, plants, fungi, etc. will bring additional issues Supaporn Phumiamorn 11 March

37 Composite of all adventitious agent testing Test Sterility (Bacteria, fungi) Mycoplasma Sucking mice Adult mice Guinea pigs Rabbits Embryonated eggs Monkeys Note Both culture and non-culture (some cases) (some cases) Supaporn Phumiamorn 11 March

38 Composite of all adventitious agent testing TEM Test Reverse Transcriptase testing (test for retroviruses) Retrovirus testing (Simian virus) Porcine parvovirus lymphocyctic choriomeningitis virus (LCM) EBV Note Supaporn Phumiamorn 11 March

39 Composite of all adventitious agent testing Human CMV Test HAV, HBV, HCV Papilloma Adeno- associated virus HHV-6, HHV-7 Mycobacterium HSV-1.-2 Note Supaporn Phumiamorn 11 March

40 Oncogenicity: the capacity of an acellular agent ( chemical, virus, viral nucleic acid, viral genes or a subcellular element to cause normal cells of an animal to form tumours. In vitro: PERT assay (retrovirus detection) TEM Supaporn Phumiamorn 11 March

41 In Vitro Induction Assays for Detection of Endogenous and Latent Viruses INDUCER IUdR, AzaC NaB, TPA Arifa S. Khan, PhD. Division of Viral Products Office of Vaccines Research and Review CBER, FDA, 2005 DETECTION ASSAYS TEM PERT (Retrovirus) Generic PCR Infectivity / Coculture 41

42 Tumourigenicity: the capacity of a cell population inoculated into an animal model to produce a tumour by proliferation at the site of inoculation and/ or at a distant site by metastasis. - the tumours are derived from the inoculated cells. Cells inoculated Supaporn Phumiamorn 11 March

43 Supaporn Phumiamorn 11 March

44 Tumourigenicity: performed in hamsters, immunosuppressed newborn rats, and nude mice at several passage levels of Vero cells at 10 6 or 10 7 cells/animal. Supaporn Phumiamorn 11 March

45 Tumourigenicity: Supaporn Phumiamorn 11 March

46 References 1. Guidance for Industry: Characterization and qualification of cell substrates and other biological materials used in the production of viral vaccines for infectious disease indications. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research. Feb Testing for the detection of mycoplasma contamination. VICH GL34 (Biologicals:Mycoplasma) Feb.2013.p Uphoff C.C and Drexler H.G. Cell culture mycoplasmas. DSMZ-German Collection of Microorganisms & Cell Cultures, Department of human and Animal cell cultures; Braunschweig, Germany Supaporn Phumiamorn 11 March

47 3.Keith Peden, Division of Viral Products OVRR, CBER, FDA: May 7, 2010 FDA s Approach to Adventitious-Agent Testing of Cell Substrates and Viral Vaccines: Traditional and Novel Methods 4. Regulatory risk evaluation on finding an adventitious agent in a marketed vaccine. WHO; Supaporn Phumiamorn 11 March

48 Supaporn Phumiamorn 11 March

Elwyn Griffiths, DSc, PhD, UK

Elwyn Griffiths, DSc, PhD, UK GaBI Educational Workshops 5 August 2018, Furama Resort Da Nang, Vietnam 1st ASEAN Overview Workshop on GMP for BIOLOGICALS/BIOSIMILARS Elwyn Griffiths, DSc, PhD, UK Former Director General, Biologics

More information

How can innovation in regulatory science inform the regulatory process to facilitate the development of new vaccines?

How can innovation in regulatory science inform the regulatory process to facilitate the development of new vaccines? How can innovation in regulatory science inform the regulatory process to facilitate the development of new vaccines? Marion F. Gruber, Ph.D. Office of Vaccines Research and Review CBER/FDA Global Vaccine

More information

In ensuring the safety of veterinary vaccines demonstration of freedom from EA is one of high importance.

In ensuring the safety of veterinary vaccines demonstration of freedom from EA is one of high importance. VICH/16/070 22 July 2016 Final Concept Paper for two VICH Guidelines: (1) general principles for detection of extraneous viruses in veterinary vaccines and defining the testing of seeds and materials of

More information

Safety Testing of Chinese Hamster Ovary (CHO) Cell Banks

Safety Testing of Chinese Hamster Ovary (CHO) Cell Banks Safety Testing of Chinese Hamster Ovary (CHO) Cell Banks Biosafety testing within the manufacturing process should be established in the early stages of drug development. We offer biosafety testing services

More information

Biopharmaceutical Drugs

Biopharmaceutical Drugs Safety Qualification of Impurities in Biopharmaceutical Drugs Impurities in Drugs: Monitoring, Safety and Regulation The Israel Chapter of PDA July, 15 16, 2008 David Jacobson-Kram, Ph.D. DABT Office of

More information

Safety Testing of Chinese Hamster Ovary (CHO) Cell Banks

Safety Testing of Chinese Hamster Ovary (CHO) Cell Banks Safety Testing of Chinese Hamster Ovary (CHO) Cell Banks About Sartorius Stedim BioOutsource Sartorius Stedim BioOutsource Ltd. is a leading provider of contract testing services to the global biopharmaceutical

More information

Effective: 9/21/2017. Revised: Institutional Animal Care and Use Committee Guiding Principles and Procedures

Effective: 9/21/2017. Revised: Institutional Animal Care and Use Committee Guiding Principles and Procedures Effective: 9/21/2017 Institutional Animal Care and Use Committee Guiding Principles and Procedures Revised: Title: Biological Materials Used in Rodents Page 1 of 6 Guiding Principle Biological materials

More information

Biosafety Considerations for Cell Based Viral Vaccines. Margaret Temple SGS Vitrology Site Director Glasgow - UK

Biosafety Considerations for Cell Based Viral Vaccines. Margaret Temple SGS Vitrology Site Director Glasgow - UK Biosafety Considerations for Cell Based Viral Vaccines Margaret Temple SGS Vitrology Site Director Glasgow - UK Presentation Outline: Sources of adventitious contamination in biological material Safety

More information

Overview of Biologics Testing and Evaluation: Regulatory Requirements and Expectations. Audrey Chang, PhD, Senior Director Development Services

Overview of Biologics Testing and Evaluation: Regulatory Requirements and Expectations. Audrey Chang, PhD, Senior Director Development Services Overview of Biologics Testing and Evaluation: Regulatory Requirements and Expectations Audrey Chang, PhD, Senior Director Development Services Definition of Biologics: PHS Act, section 351 Virus, therapeutic

More information

Novel Vaccine Technologies: Cell Substrates

Novel Vaccine Technologies: Cell Substrates Novel Vaccine Technologies: Cell Substrates William Egan, PhD. PharmaNet Consulting PDA/FDA Vaccine Conference Bethesda May 2010 Outline Cell Substrates for Live-attenuated and Inactivated Viral Vaccines

More information

A Life Cycle Approach to Raw Material Qualification for Cell and Gene Therapy Products

A Life Cycle Approach to Raw Material Qualification for Cell and Gene Therapy Products A Life Cycle Approach to Raw Material Qualification for Cell and Gene Therapy Products Angela Whatley, Ph.D. Office of Tissues and Advanced Therapies CBER/FDA CMC Strategy Forum on Cell & Gene Therapies

More information

Critical Quality Attributes for Live Viral Vaccines. Mark S. Galinski Vaccine Analytical Sciences, MedImmune, Mountain View, CA USA

Critical Quality Attributes for Live Viral Vaccines. Mark S. Galinski Vaccine Analytical Sciences, MedImmune, Mountain View, CA USA Critical Quality Attributes for Live Viral Vaccines Mark S. Galinski Vaccine Analytical Sciences, MedImmune, Mountain View, CA USA Terminology Quality Release Standards The specifications and procedures

More information

The Zombies of the Scientific Community Viruses

The Zombies of the Scientific Community Viruses The Zombies of the Scientific Community Viruses What are viruses and what do they look like? Viruses do not satisfy all of the characteristics of life. Often, viruses are called parasites because they

More information

European Medicines Agency

European Medicines Agency European Medicines Agency October 1997 CPMP/ICH/295/95 ICH Topic Q 5 A (R1) Quality of Biotechnological Products: Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal

More information

BIOPHARMACEUTICAL PROCESS EVALUATED FOR VIRAL CLEARANCE

BIOPHARMACEUTICAL PROCESS EVALUATED FOR VIRAL CLEARANCE The purpose of Viral Clearance evaluation is to assess the capability of a manufacturing production process to inactivate and/or remove potential viral contaminants. Experience and knowledge in selecting

More information

Questions and Answers on allogenic stem cell-based products for veterinary use: Specific questions on extraneous agents

Questions and Answers on allogenic stem cell-based products for veterinary use: Specific questions on extraneous agents 13 July 2017 EMA/CVMP/ADVENT/803494/2016 Committee for Medicinal Products for Veterinary Use (CVMP) Questions and Answers on allogenic stem cell-based products for veterinary use: Specific questions on

More information

PACUC Newsletter. PACUC Personnel Changes. Vol. 18, No. 1, March ~ ~ ~ ~ Brown Bag Seminars for Animal Users

PACUC Newsletter. PACUC Personnel Changes. Vol. 18, No. 1, March ~ ~ ~ ~ Brown Bag Seminars for Animal Users PACUC Newsletter Purdue Animal Care and Use Committee http://www.purdue.edu/research/ora/animals/animals-main.shtml Purdue University Vol. 18, No. 1, March 2003 E PACUC Personnel Changes ffective January

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious

More information

Dr Laszlo Palkonyay. World Health Organization

Dr Laszlo Palkonyay. World Health Organization WHO Recommendations for Evaluation of Animal Cell Cultures as Substrates for the Manufacture of Biological Medicinal Products and for the Characterization of Cell Banks (TRS 978, Annex 3) Dr Laszlo Palkonyay

More information

QPCR in Biopharmaceuticals & Current Issues. Chaminda Salgado Head of PCR Services

QPCR in Biopharmaceuticals & Current Issues. Chaminda Salgado Head of PCR Services QPCR in Biopharmaceuticals & Current Issues Chaminda Salgado Head of PCR Services Summary Biopharm lifecycle Candidate Plasmid Selection Cell Line Selection Cell Banking Process Support Potency/Stability

More information

Technical Report No. 71 Emerging Methods for Virus Detection

Technical Report No. 71 Emerging Methods for Virus Detection Technical Report No. 71 Emerging Methods for Virus Detection PDA Emerging Methods for Virus Detection Technical Report Team Authors Arifa S. Khan, Ph.D., U.S. FDA/CBER, Co-Leader Kathryn E. King, Ph.D.,

More information

Annex 2 Recommendations for the production and control of poliomyelitis vaccine (inactivated) 1

Annex 2 Recommendations for the production and control of poliomyelitis vaccine (inactivated) 1 World Health Organization WHO Technical Report Series, No. 910, 2002 Annex 2 Recommendations for the production and control of poliomyelitis vaccine (inactivated) 1 Recommendations published by WHO are

More information

Molecular & Virology Services

Molecular & Virology Services Molecular & Virology Services The laboratory staff at MQA is composed of experienced PhD level scientists whose expertise encompasses the disciplines of microbiology, molecular biology, and biochemistry.

More information

ICH CONSIDERATIONS Oncolytic Viruses

ICH CONSIDERATIONS Oncolytic Viruses European Medicines Agency Pre-authorisation Evaluation of Medicines for Human Use 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 ICH CONSIDERATIONS Oncolytic Viruses 20 November 2008 EMEA/CHMP/GTWP/607698/2008

More information

ICH Considerations. Oncolytic Viruses September 17, 2009

ICH Considerations. Oncolytic Viruses September 17, 2009 INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH Considerations Oncolytic Viruses September 17, 2009 1. Introduction Oncolytic viruses

More information

Guidance for FDA Review Staff and Sponsors

Guidance for FDA Review Staff and Sponsors Guidance for FDA Review Staff and Sponsors Content and Review of Chemistry, Manufacturing, and Control (CMC) Information for Human Gene Therapy Investigational New Drug Applications (INDs) DRAFT GUIDANCE

More information

Elwyn Griffiths, DSc, PhD, UK

Elwyn Griffiths, DSc, PhD, UK GaBI Educational Workshops 5 August 2018, Furama Resort Da Nang, Vietnam 1st ASEAN Overview Workshop on GMP for BIOLOGICALS/BIOSIMILARS Elwyn Griffiths, DSc, PhD, UK Former Director General, Biologics

More information

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS NOTE FOR GUIDANCE 1 : DNA VACCINES NON-AMPLIFIABLE IN EUKARYOTIC CELLS FOR VETERINARY USE

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS NOTE FOR GUIDANCE 1 : DNA VACCINES NON-AMPLIFIABLE IN EUKARYOTIC CELLS FOR VETERINARY USE The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Veterinary Use CVMP/IWP/07/98-FINAL COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS NOTE FOR GUIDANCE 1 : DNA VACCINES

More information

SUMMARY PROTOCOL FOR PRODUCTION AND TESTING OF MUMPS VACCINE (LIVE)

SUMMARY PROTOCOL FOR PRODUCTION AND TESTING OF MUMPS VACCINE (LIVE) WHO Technical Report Series, No. 840,1994 SUMMARY PROTOCOL FOR PRODUCTION AND TESTING OF MUMPS VACCINE (LIVE) The following protocol is intended for guidance, and indicates the information that should

More information

CHAPTER 24. Immunology

CHAPTER 24. Immunology CHAPTER 24 Diagnostic i Microbiology and Immunology Growth-Dependent Diagnostic Methods Isolation of Pathogens from Clinical Specimens Proper sampling and culture of a suspected pathogen is the most reliable

More information

Reference Materials for Adeno-Associated Viruses

Reference Materials for Adeno-Associated Viruses Reference Materials for Adeno-Associated Viruses : Recommendations of the Quality Control Sub-Committee John Chiorini (NIH-NIDCR) Paul Husak (Cell Genesys) Gabrielle Kroener-Lux (Progen) James Marich (Cell

More information

Quality Control Assays

Quality Control Assays QUALITY CONTROL An integral part of the Penn Vector Core is its robust quality control program which is carried out by a separate quality control group. Quality control assays have been developed and optimized

More information

Microbiology of Healthcare-associated Infections

Microbiology of Healthcare-associated Infections Microbiology of Healthcare-associated Infections William A. Rutala, Ph.D., M.P.H. Director, Statewide Program for Infection Control and Epidemiology and Professor of Medicine, University of North Carolina

More information

Annex 1 Recommendations a for the production and quality control of smallpox vaccine, revised 2003

Annex 1 Recommendations a for the production and quality control of smallpox vaccine, revised 2003 World Health Organization WHO Technical Report Series, No. 926, 2004 Annex 1 Recommendations a for the production and quality control of smallpox vaccine, revised 2003 Recommendations published by WHO

More information

ICH Considerations Oncolytic Viruses ONCOLYTIC VIRUSES (EMEA/CHMP/ICH/607698/2008) TRANSMISSION TO CHMP November 2008

ICH Considerations Oncolytic Viruses ONCOLYTIC VIRUSES (EMEA/CHMP/ICH/607698/2008) TRANSMISSION TO CHMP November 2008 European Medicines Agency October 2009 EMEA/CHMP/ICH/607698/2008 ICH Considerations Oncolytic Viruses ONCOLYTIC VIRUSES (EMEA/CHMP/ICH/607698/2008) TRANSMISSION TO CHMP November 2008 TRANSMISSION TO INTERESTED

More information

Cell Line Characterization and Product Testing for CHO-Derived Biopharmaceutical Products

Cell Line Characterization and Product Testing for CHO-Derived Biopharmaceutical Products Cell Line Characterization and Product Testing for CHO-Derived Biopharmaceutical Products Founded in 96, Eurofins Lancaster Laboratories is a global leader in comprehensive laboratory services enabling

More information

European Guideline for Virus Safety Evaluation of Clinical Trial Material

European Guideline for Virus Safety Evaluation of Clinical Trial Material Plasma Product Biotechnology Meeting, May 8 12, 2007 European Guideline for Virus Safety Evaluation of Clinical Trial Material Dr. Hannelore Willkommen Vice President Regulatory Affairs, NewLab Bioquality

More information

Manufacturing Viral Gene Therapy Vectors: General Approaches and Challenges John T. Gray

Manufacturing Viral Gene Therapy Vectors: General Approaches and Challenges John T. Gray Manufacturing Viral Gene Therapy s: 1 Dr. Vice President, Research & Development Audentes Therapeutics, Inc. San Francisco, USA Natural virus life cycle Late Early Viral Virally infected cell Naïve cell

More information

Yesterday s Picture UNIT 3E

Yesterday s Picture UNIT 3E Warm-Up The data above represent the results of three different crosses involving the inheritance of a gene that determines whether a certain organism is blue or white. Which of the following best explains

More information

Virus- infectious particle consisting of nucleic acid packaged in a protein coat.

Virus- infectious particle consisting of nucleic acid packaged in a protein coat. Chapter 19 Virus- infectious particle consisting of nucleic acid packaged in a protein coat. Most scientists consider viruses non-living because they cannot reproduce or carry out metabolic activities

More information

Biotechnology: Quality Assurance and Validation

Biotechnology: Quality Assurance and Validation r Biotechnology: Quality Assurance and Validation Drug Manufacturing Technology Series Volume 4 Kenneth E. Avis Carmen M. Wagner Vincent L. Wu Editors Interpharm Press, Inc. Buffalo Grove, Illinois CONTENTS

More information

REGISTRATION DOCUMENT FOR RECOMBINANT & SYNTHETIC DNA RESEARCH

REGISTRATION DOCUMENT FOR RECOMBINANT & SYNTHETIC DNA RESEARCH IBC Date Received: Reg. Doc. No.: REGISTRATION DOCUMENT FOR RECOMBINANT & SYNTHETIC DNA RESEARCH Principal Investigator: --------------------------------------- Position Title: -------------- Department:

More information

5.14. GENE TRANSFER MEDICINAL PRODUCTS FOR HUMAN USE. Recombinant vectors Gene transfer medicinal products for human use

5.14. GENE TRANSFER MEDICINAL PRODUCTS FOR HUMAN USE. Recombinant vectors Gene transfer medicinal products for human use EUROPEAN PHARMACOPOEIA 6.0 5.14. Gene transfer medicinal products for human use 01/2008:51400 corrected 6.0 5.14. GENE TRANSFER MEDICINAL PRODUCTS FOR HUMAN USE This general chapter is published for information.

More information

Novel Virus Clearance and Virus Detection Technologies and Applications

Novel Virus Clearance and Virus Detection Technologies and Applications Novel Virus Clearance and Virus Detection Technologies and Applications Qi Chen, PhD Process Virology, Purification Development Genentech Inc., A Member of the Roche Group CMC Forum Japan December 3, 2018

More information

Recommendations to assure the quality, safety and efficacy of recombinant hepatitis B vaccines

Recommendations to assure the quality, safety and efficacy of recombinant hepatitis B vaccines Annex 4 Recommendations to assure the quality, safety and efficacy of recombinant hepatitis B vaccines Replacement of Annex 2 of WHO Technical Report Series, No. 786 and Annex 4 of WHO Technical Report

More information

Viruses 11/30/2015. Chapter 19. Key Concepts in Chapter 19

Viruses 11/30/2015. Chapter 19. Key Concepts in Chapter 19 Chapter 19 Viruses Dr. Wendy Sera Houston Community College Biology 1406 Key Concepts in Chapter 19 1. A virus consists of a nucleic acid surrounded by a protein coat. 2. Viruses replicate only in host

More information

Viruses. Chapter 19. Biology Eighth Edition Neil Campbell and Jane Reece. PowerPoint Lecture Presentations for

Viruses. Chapter 19. Biology Eighth Edition Neil Campbell and Jane Reece. PowerPoint Lecture Presentations for Chapter 19 Viruses PowerPoint Lecture Presentations for Biology Eighth Edition Neil Campbell and Jane Reece Lectures by Chris Romero, updated by Erin Barley with contributions from Joan Sharp Copyright

More information

Polymerase Chain Reaction

Polymerase Chain Reaction Polymerase Chain Reaction Variations of PCR in the Diagnostic Lab The most common variations of standard PCR used in the diagnostic laboratory are: Reverse Transcriptase PCR (RT-PCR) Nested PCR (n-pcr)

More information

TOPICS GENERAL BACTERIOLOGY

TOPICS GENERAL BACTERIOLOGY II year (2st semester) Scientific Field MICROBIOLOGY TUTOR ECTS PICA F. COORDINATOR MED/07 Microbiology Ceccherini Silberstein 1 Francesca MED/07 Microbiology Pica Francesca 5 MED/07 Microbiology Svicher

More information

Viruses. Chapter 19. Biology Eighth Edition Neil Campbell and Jane Reece. PowerPoint Lecture Presentations for

Viruses. Chapter 19. Biology Eighth Edition Neil Campbell and Jane Reece. PowerPoint Lecture Presentations for Chapter 19 Viruses PowerPoint Lecture Presentations for Biology Eighth Edition Neil Campbell and Jane Reece Lectures by Chris Romero, updated by Erin Barley with contributions from Joan Sharp Copyright

More information

Microbial Biotechnology agustin krisna wardani

Microbial Biotechnology agustin krisna wardani Microbial Biotechnology agustin krisna wardani 1. The Structure of Microbes Microbes (microorganisms) are tiny organisms that are too small to be seen individually by the naked eye and must be viewed with

More information

The Molecular Virology Support Core: Adenoviral Vectors and Beyond

The Molecular Virology Support Core: Adenoviral Vectors and Beyond The : Adenoviral Vectors and Beyond Christoph A. Kahl, Ph.D. Viral Vector Workshop, May 5th, 2011 Outline 1) Overview of the MVSC 2) Adenoviral Vectors 3) Expertise and Services Overview What does the

More information

New proposal from the EC:

New proposal from the EC: New proposal from the EC: Gene therapy medicinal product means a biological medicinal product which has the following characteristics: a. it contains an active substance which contains or consists of a

More information

REGISTRATION DOCUMENT FOR RECOMBINANT DNA RESEARCH

REGISTRATION DOCUMENT FOR RECOMBINANT DNA RESEARCH EHRS Date Received: Reg. Doc. No.: REGISTRATION DOCUMENT FOR RECOMBINANT DNA RESEARCH Principal Investigator: Penn ID#: Position Title: School: Department: Mailing Address: Mail Code: Telephone: FAX: E-mail:

More information

Regulation of metabolic pathways

Regulation of metabolic pathways Regulation of metabolic pathways Bacterial control of gene expression Operon: cluster of related genes with on/off switch Three Parts: 1. Promoter where RNA polymerase attaches 2. Operator on/off, controls

More information

Issued by: LABORATORY MANAGER Original Date: March 14, 2001 Approved by: Laboratory Director Revision Date: October 10, 2003 CEREBRAL SPINAL FLUID

Issued by: LABORATORY MANAGER Original Date: March 14, 2001 Approved by: Laboratory Director Revision Date: October 10, 2003 CEREBRAL SPINAL FLUID Policy # MI/VIR/03/v02 Page 1 of 5 Section: Subject Title: Cerebral Spinal Fluid (CSF) Issued by: LABORATORY MANAGER Original Date: March 14, 2001 Approved by: Laboratory Director Revision Date: October

More information

HOMEOPATHIC MEDICINAL PRODUCT WORKING GROUP (HMPWG) POINTS TO CONSIDER ON SAFETY OF HOMEOPATHIC MEDICINAL PRODUCTS FROM BIOLOGICAL ORIGIN

HOMEOPATHIC MEDICINAL PRODUCT WORKING GROUP (HMPWG) POINTS TO CONSIDER ON SAFETY OF HOMEOPATHIC MEDICINAL PRODUCTS FROM BIOLOGICAL ORIGIN HOMEOPATHIC MEDICINAL PRODUCT WORKING GROUP (HMPWG) POINTS TO CONSIDER ON SAFETY OF HOMEOPATHIC MEDICINAL PRODUCTS FROM BIOLOGICAL ORIGIN DISCUSSION IN THE HMPWG January 2001-April 2005 RELEASE FOR CONSULTATION

More information

Global Biological Resource Leader

Global Biological Resource Leader Custom Solutions Partner with the Global Biological Resource Leader Since 1925, ATCC has set the standard for the manufacture, characterization, preservation, storage and distribution of biological materials.

More information

NOTES: CH 19 - The Genetics of Viruses

NOTES: CH 19 - The Genetics of Viruses NOTES: CH 19 - The Genetics of Viruses Overview: Microbial Model Systems Viruses called bacteriophages can infect and set in motion a genetic takeover of bacteria, such as Escherichia coli E. coli and

More information

Methods that do not require growth in laboratory PCR

Methods that do not require growth in laboratory PCR Methods that do not require growth in laboratory PCR Nucleotide sequencing MLST/MLVST Profiles Microarrays Polymerase Chain Reaction [PCR] Use to find a rare sequence in a pool of many different sequences

More information

Lentiviral Vector Reference Material (LVV RM) Request for Proposal RFP 1.0 Vector Production and Purification

Lentiviral Vector Reference Material (LVV RM) Request for Proposal RFP 1.0 Vector Production and Purification Lentiviral Vector Reference Material (LVV RM) Request for Proposal RFP 1.0 Vector Production and Purification 1.0 Introduction This document is a Request for Proposal (RFP 1.0) for any organization to

More information

Lecture Series 10 The Genetics of Viruses and Prokaryotes

Lecture Series 10 The Genetics of Viruses and Prokaryotes Lecture Series 10 The Genetics of Viruses and Prokaryotes The Genetics of Viruses and Prokaryotes A. Using Prokaryotes and Viruses for Genetic Experiments B. Viruses: Reproduction and Recombination C.

More information

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP) REVISED GUIDELINE ON

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP) REVISED GUIDELINE ON European Medicines Agency Veterinary Medicines and Inspections London, 9 November 2005 Doc. Ref. COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP) REVISED GUIDELINE ON REQUIREMENTS AND CONTROLS

More information

Growing Together: How Viruses Have Shaped Human Evolution. Shirlee Wohl Katherine Wu

Growing Together: How Viruses Have Shaped Human Evolution. Shirlee Wohl Katherine Wu Growing Together: How Viruses Have Shaped Human Evolution Shirlee Wohl Katherine Wu What comes to your mind when you hear the word virus? flu public health cold vaccine infection disease cough biology

More information

Dr: RAWIA BADR Associate Professor of Microbiology&Immunology

Dr: RAWIA BADR Associate Professor of Microbiology&Immunology Dr: RAWIA BADR Associate Professor of Microbiology&Immunology Cell culture Commonly refers to the culture of animal cells and tissues, while the more specific term plant tissue.culture is used only for

More information

Registration Document For Biohazards

Registration Document For Biohazards Protocol #: Registration Document For Biohazards All applicants are required to complete the following sections: Principal Investigator Information Location of Study Section A: General Administrative Information

More information

January 5,

January 5, Holland Cross, Tower B 6 th Floor, 1600 Scott Street Address Locator # 3106B OTTAWA, Ontario K1A 1B6 January 5, 2001 00-022591 To Associations: I am pleased to inform you of the release of the International

More information

QIAGEN - Evolution from Tool to System Provider in MDx 3 Levels of QIAGEN Product Offering for Different Customer Types

QIAGEN - Evolution from Tool to System Provider in MDx 3 Levels of QIAGEN Product Offering for Different Customer Types QIAGEN Molecular Diagnostics Molecular Diagnostics Solutions for Clinical Diagnostic Labs - 1- QIAGEN - Evolution from Tool to System Provider in MDx 3 Levels of QIAGEN Product Offering for Different Customer

More information

Diagnostic Virology. Diagnostic Virology

Diagnostic Virology. Diagnostic Virology Diagnostic Virology Diagnostic Virology The purpose is to diagnose viral diseases in the patient This can be achieved by: Directly detecting the virus or viral products Indirectly detecting an immunological

More information

Accredited Laboratory

Accredited Laboratory Accredited Laboratory A2LA has accredited St. Paul, MN for technical competence in the field of Biological Testing This laboratory is accredited in accordance with the recognized International Standard

More information

Chapter 18. Viral Genetics. AP Biology

Chapter 18. Viral Genetics. AP Biology Chapter 18. Viral Genetics AP Biology What is a virus? Is it alive? DNA or RNA enclosed in a protein coat Viruses are not cells Extremely tiny electron microscope size smaller than ribosomes ~20 50 nm

More information

Viruses. Chapter 19. Biology Eighth Edition Neil Campbell and Jane Reece. PowerPoint Lecture Presentations for

Viruses. Chapter 19. Biology Eighth Edition Neil Campbell and Jane Reece. PowerPoint Lecture Presentations for Chapter 19 Viruses PowerPoint Lecture Presentations for Biology Eighth Edition Neil Campbell and Jane Reece Lectures by Chris Romero, updated by Erin Barley with contributions from Joan Sharp Copyright

More information

Monitoring the Safety of Stem Cell Based Therapeutics in Clinical Trials. Jane Lebkowski Ph.D. ASGCT May 18, 2010

Monitoring the Safety of Stem Cell Based Therapeutics in Clinical Trials. Jane Lebkowski Ph.D. ASGCT May 18, 2010 Monitoring the Safety of Stem Cell Based Therapeutics in Clinical Trials Jane Lebkowski Ph.D. ASGCT May 18, 2010 Disclosure Received salary & ownership interest from Geron Corporation as an employee. Multiple

More information

Health monitoring. Research Models and Services. Serology. The Envigo advantage

Health monitoring. Research Models and Services. Serology. The Envigo advantage Research Models and Services Health monitoring The disease status of laboratory animals has improved significantly over the last 25 years. This has resulted in the increased availability of animals free

More information

Detection and Quantitation of Residual Host Cell DNA

Detection and Quantitation of Residual Host Cell DNA Detection and Quantitation of Residual Host Cell DNA White Paper Author: Phil Kuhlman, Biopharmaceutical Technical Specialist 1 Abstract All biological drug products are required to be characterised for

More information

ICH Considerations on Viral/Vector Shedding; and Overview of Gene Therapy Activity in Canada

ICH Considerations on Viral/Vector Shedding; and Overview of Gene Therapy Activity in Canada ICH Considerations on Viral/Vector Shedding; and Overview of Gene Therapy Activity in Canada Anthony Ridgway, Ph.D. Senior Regulatory Scientist Biologics & Genetic Therapies Directorate Health Canada Open

More information

Gene Technology classification of dealings involving self-inactivating, replication defective, retroviral vectors.

Gene Technology classification of dealings involving self-inactivating, replication defective, retroviral vectors. Gene Technology classification of dealings involving self-inactivating, replication defective, retroviral vectors. The use of replication defective, retroviral vectors for research purposes has become

More information

LECTURE PRESENTATIONS

LECTURE PRESENTATIONS LECTURE PRESENTATIONS For CAMPBELL BIOLOGY, NINTH EDITION Jane B. Reece, Lisa A. Urry, Michael L. Cain, Steven A. Wasserman, Peter V. Minorsky, Robert B. Jackson Chapter 19 Viruses Lectures by Erin Barley

More information

FDA Perspective on the Preclinical Development of Cancer Vaccines

FDA Perspective on the Preclinical Development of Cancer Vaccines FDA Perspective on the Preclinical Development of Cancer Vaccines Richard D. McFarland Ph.D., M.D. Medical Officer CBER/OCTGT/DCEPT mcfarlandr@cber.fda.gov Cancer Vaccine Clinical Trials Workshop Alexandria,

More information

Viruses. Chapter 19. Biology Eighth Edition Neil Campbell and Jane Reece. PowerPoint Lecture Presentations for

Viruses. Chapter 19. Biology Eighth Edition Neil Campbell and Jane Reece. PowerPoint Lecture Presentations for Chapter 19 Viruses PowerPoint Lecture Presentations for Biology Eighth Edition Neil Campbell and Jane Reece Lectures by Chris Romero, updated by Erin Barley with contributions from Joan Sharp Copyright

More information

Beth Hutchins, PhD PhRMA ICH Gene Therapy Discussion Group

Beth Hutchins, PhD PhRMA ICH Gene Therapy Discussion Group ICH Considerations on General Principles to Address the Risk of Inadvertent Germline Integration of Gene Therapy Vectors and Current Topics on Gene Therapy in USA Beth Hutchins, PhD PhRMA ICH Gene Therapy

More information

Index 311. overview, 84, 85 pretreatment, 85 probe preparation, 85 washing, 85, 91. G GeneChip, see DNA microarray

Index 311. overview, 84, 85 pretreatment, 85 probe preparation, 85 washing, 85, 91. G GeneChip, see DNA microarray Index 309 Index A AIDS, see Human immunodeficiency virus Allelotyping, microdissection advantages, 69, 70 ovarian cancer, data acquisition and analysis, 74 DNA extraction, 72, 73, 76 materials, 70, 71

More information

The 5 end problem. 3 5 Now what? RNA primers. DNA template. elongate. excise primers, elongate, ligate

The 5 end problem. 3 5 Now what? RNA primers. DNA template. elongate. excise primers, elongate, ligate 1 2 3 DNA Replication Viruses must replicate their genomes to make new progeny This always requires expression of at least one virus protein, sometimes many (hence always delayed after infection) DNA is

More information

Practice Problems 5. Location of LSA-GFP fluorescence

Practice Problems 5. Location of LSA-GFP fluorescence Life Sciences 1a Practice Problems 5 1. Soluble proteins that are normally secreted from the cell into the extracellular environment must go through a series of steps referred to as the secretory pathway.

More information

Calvin College Biosafety Application

Calvin College Biosafety Application SECTION 1: GENERAL INFORMATION Calvin College Biosafety Application Applicant Name: Campus Address: Email Address: Campus Phone #: Project Title: APPLICATION TYPE: Research Teaching Course #(s) PROTOCOL

More information

Name Block Desk # BACTERIA AND VIRUSES. 1. What are prokaryotes? They are -celled organisms with no

Name Block Desk # BACTERIA AND VIRUSES. 1. What are prokaryotes? They are -celled organisms with no Name Block Desk # BACTERIA AND VIRUSES Identifying Bacteria: 1. What are prokaryotes? They are -celled organisms with no - bound organelles. 2. True or false: prokaryotes are much larger that eukaryotes.

More information

5. the transformation of the host cell. 2. reject the virus. 4. initiate an attack on the virus.

5. the transformation of the host cell. 2. reject the virus. 4. initiate an attack on the virus. Version 001 Bacterial/Viral Genetics mahon (26) 1 This print-out should have 28 questions. Multiple-choice questions may continue on the next column or page find all choices before answering. Holt Bio

More information

Course Descriptions. BIOL: Biology. MICB: Microbiology. [1]

Course Descriptions. BIOL: Biology. MICB: Microbiology.  [1] Course Descriptions BIOL: Biology http://www.calendar.ubc.ca/vancouver/courses.cfm?code=biol [1] BIOL 112 (3) Biology of the Cell The principles of cellular and molecular biology using bacterial and eukaryotic

More information

Chapter 10: Classification of Microorganisms

Chapter 10: Classification of Microorganisms Chapter 10: Classification of Microorganisms 1. The Taxonomic Hierarchy 2. Methods of Identification 1. The Taxonomic Hierarchy Phylogenetic Tree of the 3 Domains Taxonomic Hierarchy 8 successive taxa

More information

2014 Pearson Education, Inc. CH 8: Recombinant DNA Technology

2014 Pearson Education, Inc. CH 8: Recombinant DNA Technology CH 8: Recombinant DNA Technology Biotechnology the use of microorganisms to make practical products Recombinant DNA = DNA from 2 different sources What is Recombinant DNA Technology? modifying genomes

More information

Name 10 Molecular Biology of the Gene Test Date Study Guide You must know: The structure of DNA. The major steps to replication.

Name 10 Molecular Biology of the Gene Test Date Study Guide You must know: The structure of DNA. The major steps to replication. Name 10 Molecular Biology of the Gene Test Date Study Guide You must know: The structure of DNA. The major steps to replication. The difference between replication, transcription, and translation. How

More information

Chapter 20 Recombinant DNA Technology. Copyright 2009 Pearson Education, Inc.

Chapter 20 Recombinant DNA Technology. Copyright 2009 Pearson Education, Inc. Chapter 20 Recombinant DNA Technology Copyright 2009 Pearson Education, Inc. 20.1 Recombinant DNA Technology Began with Two Key Tools: Restriction Enzymes and DNA Cloning Vectors Recombinant DNA refers

More information

IBC protocol Risk Assessment and Determination of NIH Guidelines

IBC protocol Risk Assessment and Determination of NIH Guidelines IBC protocol Risk Assessment and Determination of NIH Guidelines The following are points to consider when reviewing all protocols for risk, recommended containment conditions, and determine applicable

More information

Therapeutic Proteins BIT 230

Therapeutic Proteins BIT 230 Therapeutic Proteins BIT 230 CLOTTING Haemophilia Benefix Blood Products ANTICOAGULANT THROMBOLYTIC AGENTS tissue plasminogen activator streptokinase Coagulation pathway Factor VIII (Haemophilia A) Factor

More information

Livestock Diagnostic Products for Swine. Kylt Professional in vitro Diagnostic Solutions.

Livestock Diagnostic Products for Swine. Kylt Professional in vitro Diagnostic Solutions. Livestock Diagnostic Products for Swine Kylt Professional in vitro Diagnostic Solutions www.kylt.eu 2018/2019 Kylt Real-Time (RT-) PCR assays for Swine Kylt provides veterinary diagnostic laboratories

More information

Gene Technology classification of dealings involving self-inactivating, replication defective, retroviral vectors.

Gene Technology classification of dealings involving self-inactivating, replication defective, retroviral vectors. Gene Technology classification of dealings involving self-inactivating, replication defective, retroviral vectors. The use of replication defective, retroviral vectors for research purposes has become

More information

The Biotechnology Toolbox

The Biotechnology Toolbox Chapter 15 The Biotechnology Toolbox Cutting and Pasting DNA Cutting DNA Restriction endonuclease or restriction enzymes Cellular protection mechanism for infected foreign DNA Recognition and cutting specific

More information

Skidmore College Institutional Biosafety Committee (IBC) Protocol Registration Form

Skidmore College Institutional Biosafety Committee (IBC) Protocol Registration Form Skidmore College Institutional Biosafety Committee (IBC) Protocol Registration Form Please return completed form to Loretta Greenholtz, 424 Palamountain Hall. IBC Reg. No: Risk Group: General Instructions:

More information

Sensitivity vs Specificity

Sensitivity vs Specificity Viral Detection Animal Inoculation Culturing the Virus Definitive Length of time Serology Detecting antibodies to the infectious agent Detecting Viral Proteins Western Blot ELISA Detecting the Viral Genome

More information

Viral Clearance Studies

Viral Clearance Studies Viral Clearance Studies viral clearance studies from the industry leader with unmatched experience and expertise Viral clearance is a critical component of regulatory submissions as it helps demonstrate

More information